Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization BioSyngen Pte Ltd.Startup |
Active Organization BioSyngen Pte Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 1 | - | BioSyngen Pte Ltd.Startup | 30 Nov 2024 |